Insider filing · CADL
William Garrett Nichols
Chief Medical Officer
profile →
Candel Therapeutics, Inc.
CADL · Healthcare · 17 filings in 24 months
ticker →
William Garrett Nichols sold $397K of Candel Therapeutics (CADL)
Executed Mar 18 2025, disclosed Mar 20 2025, 2 days later.
Value, as filed
$397K
45,316 sh × $8.76
Executed
Mar 18 2025
the trade date, as filed
Disclosed
Mar 20 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
WNWilliam Garrett Nichols (Chief Medical Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Candel Therapeutics, Inc. (CADL). The largest single filing was $397K of CADL (45,316 sh × $8.76, as filed), executed Mar 18 2025.
The name
CADLHealthcare · Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→